Daiwa Securities Group
CABA icon

Daiwa Securities Group’s Cabaletta Bio CABA Stock Holding History

Daiwa Securities Group’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-175
Closed -$1K – 1288
2024
Q3 		$1K Hold
175
– – ﹤0.01% 1246
2024
Q2 		$1K Hold
175
– – ﹤0.01% 1284
2024
Q1 		$3K Hold
175
– – ﹤0.01% 1235
2023
Q4 		$4K Buy
+175
New +$2.94K ﹤0.01% 1220
2022
Q4 		– Sell
-45
Closed – – 1325
2022
Q3 		$0 Hold
45
– – ﹤0.01% 1344
2022
Q2 		$0 Hold
45
– – ﹤0.01% 1367
2022
Q1 		$0 Hold
45
– – ﹤0.01% 1381
2021
Q4 		$0 Hold
45
– – ﹤0.01% 1397
2021
Q3 		$1K Hold
45
– – ﹤0.01% 1263
2021
Q2 		$0 Hold
45
– – ﹤0.01% 1261
2021
Q1 		$0 Hold
45
– – ﹤0.01% 1271
2020
Q4 		$1K Buy
+45
New +$584 ﹤0.01% 1167

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's CABA Position: Q4 2024 in Review

Daiwa Securities Group sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 175 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in CABA in Q4 2020 and held it in 12 quarters. The position peaked at $4K in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • Daiwa Securities Group reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 175 Cabaletta Bio shares in Q4 2024, an estimated $1K.
  • Daiwa Securities Group first reported a position in Cabaletta Bio in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Cabaletta Bio position peaked at $4K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.